2m 2m 2m 2m 2m 2m 2m
OSCAR HEALTH-A (OSCR)
NYSE
$29.90-$0.03 (-0.10%)
Price as of Jun 23, 2026 7:54 PM EDT- $7.6BMarket Cap
- 39.76%1-Year Change
- Healthcare PlansIndustry
OSCAR HEALTH-A (OSCR)
$29.90-$0.03 (-0.10%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 11.7B +27.50% | 9.2B +56.54% | 5.9B +47.92% | 4.0B +115.57% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 11.7B +27.50% | 9.2B +56.54% | 5.9B +47.92% | 4.0B +115.57% | |
Sales and Marketing Expense | 2.0B +16.76% | 1.8B N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 28.9M -10.12% | 32.1M +4.73% | 30.7M +100.84% | 15.3M +4.64% | |
Total Operating Expenses | 12.1B +32.65% | 9.1B +49.55% | 6.1B +33.93% | 4.6B +91.07% | |
Operating Profit | -396.4M -792.15% | 57.3M +124.30% | -235.6M -60.06% | -589.9M +8.34% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | -1.3M -700.94% | |
Interest Expense | -13.1M -42.15% | -22.7M -7.71% | -24.6M +8.75% | -22.6M +379.30% | |
Interest Income and Expense and Net | -13.1M -42.15% | -22.7M -7.71% | -24.6M +2.95% | -23.9M +430.10% | |
Total Nonoperating Income and Expense | -23.3M +22,127.62% | -105,000 -98.52% | -7.1M -131.30% | 22.6M +379.30% | |
Income before Taxes | -437.3M -1,408.25% | 33.4M +112.51% | -267.3M -56.19% | -610.1M +6.92% | |
Income Taxes | 5.6M -23.26% | 7.3M +121.77% | 3.3M +729.83% | -523,000 -161.82% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -443.2M -1,842.49% | 25.4M +109.39% | -270.7M -55.35% | -606.3M +5.88% | |
Net Income from Continuing Operations Applicable to Common | -437.3M -1,408.25% | 33.4M +112.51% | -267.3M -56.19% | -610.1M +6.92% | |
Basic EPS and Net Income | -1.69 -1,636.36% | 0.11 +109.02% | -1.22 -57.19% | -2.85 -10.94% | |
Diluted EPS and Net Income | -1.69 -1,790.00% | 0.10 +108.20% | -1.22 -57.19% | -2.85 -10.94% | |
Basic Weighted Average Shares | 262.4M +9.15% | 240.4M +8.45% | 221.7M +4.32% | 212.5M +18.72% | |
Diluted Weighted Average Shares | 262.4M -1.30% | 265.9M +19.94% | 221.7M +4.32% | 212.5M +18.72% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.8B +81.65% | 1.5B -18.35% | 1.9B +20.00% | 1.6B +41.18% | |
Short-Term Investments | 1.2B +94.80% | 624.5M -9.48% | 689.8M -50.63% | 1.4B +138.00% | |
Cash and Cash Equivalents and Short-Term Investments | 4.0B +85.47% | 2.2B -15.96% | 2.6B -13.39% | 3.0B +74.79% | |
Total Current Assets | 4.6B +62.15% | 2.8B -7.05% | 3.1B -25.73% | 4.1B +78.74% | |
Accumulated Depreciation | 141.6M +24.14% | 114.1M +29.55% | 88.1M +53.49% | 57.4M +36.30% | |
Property and Plant and Equipment and Net | 88.3M +32.27% | 66.8M +7.85% | 61.9M +3.41% | 59.9M +28.48% | |
Total Long-Term Assets | 119.7M +45.30% | 82.4M -1.05% | 83.3M -12.12% | 94.8M -1.25% | |
Total Assets | 6.3B +30.68% | 4.8B +34.40% | 3.6B -20.44% | 4.5B +36.28% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 4.9B +40.41% | 3.5B +42.58% | 2.4B -25.58% | 3.3B +76.21% | |
Total Long-Term Debt | 430.1M +43.58% | 299.6M +0.26% | 298.8M +0.26% | 298.0M N/A | |
Total Long-Term Liabilities | 52.0M -15.16% | 61.3M -9.31% | 67.6M -6.51% | 72.3M -5.93% | |
Total Liabilities | 5.3B +39.76% | 3.8B +36.80% | 2.8B -23.08% | 3.6B +88.39% | |
Retained Earnings | -3.3B +15.54% | -2.9B -0.88% | -2.9B +10.39% | -2.6B +30.32% | |
Total Stockholders Equity | 977.6M -3.55% | 1.0B +26.07% | 804.0M -9.71% | 890.4M -35.82% | |
Total Shares Outstanding | 261.9M +4.54% | 250.5M +9.20% | 229.4M +6.06% | 216.3M +587.63% | |
Cash Flow | |||||
Cash from Operating Activities | 1.1B +11.93% | 978.2M +459.42% | -272.2M -171.56% | 380.3M +309.28% | |
Capital Expenditures | 36.4M +30.38% | 27.9M +9.07% | 25.6M -11.84% | 29.0M +12.08% | |
Cash from Investing Activities | -241.1M -82.63% | -1.4B -340.38% | 577.2M +354.81% | -226.5M -70.75% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 399.2M +483.74% | 68.4M +960.94% | 6.4M -97.86% | 301.1M -75.69% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -3.39% -642.84% | 0.62% +115.53% | -4.02% -73.00% | -14.88% N/A | |
Return on Assets | -7.94% -1,417.44% | 0.60% +109.04% | -6.66% -56.88% | -15.45% N/A | |
Return on Equity | -44.51% -1,690.50% | 2.80% +108.76% | -31.96% -39.97% | -53.24% N/A | |
Revenue Growth | 27.50% -51.36% | 56.54% +17.99% | 47.92% -58.54% | 115.57% N/A | |
Current Ratio | 0.95 +15.50% | 0.82 -34.81% | 1.26 -0.21% | 1.26 N/A | |
Cash Ratio | 0.57 +29.37% | 0.44 -42.73% | 0.77 +61.26% | 0.48 N/A | |
Debt-to-Equity Ratio | 0.44 +48.87% | 0.30 -20.48% | 0.37 +11.02% | 0.33 N/A | |
Debt-to-Assets Ratio | 0.07 +9.85% | 0.06 -25.42% | 0.08 +26.14% | 0.07 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow